Search Within

Konstantin V Dobrenkov

Formats
  1. Journal Article (9)
  2. Meeting Abstract (2)
Groups
  1. GSK Faculty (11)
  2. Center for Molecular Imaging and Biotechnology (CMIB) (8)
  3. Molecular Pharmacology and Chemistry Program Faculty (7)
  4. Sloan Kettering Institute Faculty (7)
  5. Radiochemistry and Imaging Sciences Service (6)
  6. Radiology, Department of (6)

More Groups

People
  1. Vladimir Ponomarev (6)
  2. Larissa Shenker (5)
  3. Hedvig Hricak (4)
  4. Malgorzata Olszewska (4)
  5. Michel Sadelain (4)
  6. Nai-Kong Cheung (4)

More People

Years
  1. 2017 (1)
  2. 2016 (2)
  3. 2014 (1)
  4. 2010 (1)
  5. 2009 (2)
  6. 2008 (2)

More Years

Publications
  1. Journal of Nuclear Medicine (3)
  2. Cytotherapy (1)
  3. European Journal of Nuclear Medicine and Molecular Imaging (1)
  4. Journal of Biomedical Optics (1)
  5. Journal of Clinical Oncology (1)
  6. Nature Medicine (1)

More Publications

Publishers
  1. Society of Nuclear Medicine (3)
  2. American Society of Clinical Oncology (1)
  3. Elsevier Inc. (1)
  4. Elsevier Science Ltd. (1)
  5. Landes Bioscience (1)
  6. Nature Publishing Group (1)

More Publishers

Results (11)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Bispecific antibody does not induce T-cell death mediated by chimeric antigen receptor against disialoganglioside GD2
    Journal Article

    Hoseini, S. S.; Dobrenkov, K.; Pankov, D.; Xu, X. L.; Cheung, N. K. V.
    OncoImmunology (2017)

    Fulltext@MSK | Save
  • GD2/GD3 expression: Companion diagnostic for ganglioside-targeted immunotherapy against pediatric solid tumors
    Meeting Abstract

    Dobrenkov, K.; Ostrovnaya, I.; Cheung, I. Y.; Feng, Y.; Cheung, N. K. V.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Oncotargets GD2 and GD3 are highly expressed in sarcomas of children, adolescents, and young adults
    Journal Article

    Dobrenkov, K.; Ostrovnaya, I.; Gu, J.; Cheung, I. Y.; Cheung, N. K. V.
    Pediatric Blood and Cancer (2016)

    Fulltext@MSK | Save
  • GD2-targeted immunotherapy and radioimmunotherapy
    Journal Article

    Dobrenkov, K.; Cheung, N. K. V.
    Seminars in Oncology (2014)

    Fulltext@MSK | Save
  • A new pyrimidine-specific reporter gene: A mutated human deoxycytidine kinase suitable for PET during treatment with acycloguanosine-based cytotoxic drugs
    Journal Article

    Likar, Y.; Zurita, J.; Dobrenkov, K.; Shenker, L.; Cai, S.; Neschadim, A.; Medin, J. A.; Sadelain, M.; Hricak, H.; Ponomarev, V.
    Journal of Nuclear Medicine (2010)

    Fulltext@MSK | Save
  • PET imaging of HSV1-tk mutants with acquired specificity toward pyrimidine- and acycloguanosine-based radiotracers
    Journal Article

    Likar, Y.; Dobrenkov, K.; Olszewska, M.; Shenker, L.; Cai, S.; Hricak, H.; Ponomarev, V.
    European Journal of Nuclear Medicine and Molecular Imaging (2009)

    Fulltext@MSK | Save
  • Registration of planar bioluminescence to magnetic resonance and x-ray computed tomography images as a platform for the development of bioluminescence tomography reconstruction algorithms
    Journal Article

    Beattie, B. J.; Klose, A. D.; Le, C. H.; Longo, V. A.; Dobrenkov, K.; Vider, J.; Koutcher, J. A.; Blasberg, R. G.
    Journal of Biomedical Optics (2009)

    Fulltext@MSK | Save
  • A new acycloguanosine-specific supermutant of herpes simplex virus type 1 thymidine kinase suitable for PET imaging and suicide gene therapy for potential use in patients treated with pyrimidine-based cytotoxic drugs
    Journal Article

    Likar, Y.; Dobrenkov, K.; Olszewska, M.; Vider, E.; Shenker, L.; Cai, S.; Pillarsetty, N.; Hricak, H.; Ponomarev, V.
    Journal of Nuclear Medicine (2008)

    Fulltext@MSK | Save
  • Monitoring the efficacy of adoptively transferred prostate cancer-targeted human T lymphocytes with PET and bioluminescence imaging
    Journal Article

    Dobrenkov, K.; Olszewska, M.; Likar, Y.; Shenker, L.; Gunset, G.; Cai, S.; Pillarsetty, N.; Hricak, H.; Sadelain, M.; Ponomarev, V.
    Journal of Nuclear Medicine (2008)

    Fulltext@MSK | Save
  • T cell-encoded CD80 and 4-1BBL induce auto- and transcostimulation, resulting in potent tumor rejection
    Journal Article

    Stephan, M. T.; Ponomarev, V.; Brentjens, R. J.; Chang, A. H.; Dobrenkov, K. V.; Heller, G.; Sadelain, M.
    Nature Medicine (2007)

    Fulltext@MSK | Save